Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
3.900
+0.005 (0.13%)
At close: Dec 5, 2025, 4:00 PM EST
3.920
+0.020 (0.51%)
After-hours: Dec 5, 2025, 4:10 PM EST
Athira Pharma Market Cap
Athira Pharma has a market cap or net worth of $15.58 million as of December 5, 2025. Its market cap has decreased by -37.21% in one year.
Market Cap
15.58M
Enterprise Value
-8.74M
1-Year Change
-37.21%
Ranking
Category
Stock Price
$3.90
Market Cap Chart
Since the IPO on September 18, 2020, Athira Pharma's market cap has decreased from $489.85M to $15.58M, a decrease of -96.82%. That is a compound annual growth rate of -48.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 15.36M | -32.29% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | 1.11B | 127.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |